Announced
Completed
Synopsis
Somerset Indus Capital Partners, a provider of private equity and equity-related investments, completed the acquisition of a minority stake in Emil Pharmaceuticals, is a company responisble for creating, producing, and selling medications of a quality that is recognised worldwide. Financial terms were not disclosed.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.